Abstract P3-07-13: the Next Generation Oral Selective Estrogen Receptor Degrader (SERD) Camizestrant (AZD9833) is Active Against Wild Type and Mutant Estrogen Receptor Α Christopher Morrow , Larissa Carnevalli , Richard D. Baird , Tim Brier , Carmela Ciardullo , Natalie Cureton , Mandy Lawson , Robert McEwen , Myria Nikolaou , Anne Armstrong , Begoña Bermejo , Emiliano Calvo , Eva Ciruelos , Javier Garcia-Corbacho , Erika Hamilton , Jason Incorvati , Peter Kabos , Mafalda Oliveira , Manish R Patel , Manuel Ruiz-Borregó , Nicholas Turner , Chris Twelves , Christos Vaklavas , Danielle Carroll , Steven Ching , Nevena Cvetesic , Michelle DuPont , Lisa Gibbons , Alastair Mathewson , Rhiannon Maudsley , Pablo Morentin Gutierrez , Avinash Reddy , Jaime Rodriguez-Canales , Susana Ros , Dhivya Sudhan , Andy Sykes , David Whitson , Teresa Klinowska , Justin Lindemann Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
